AIP.NASDAQArteris, INC

Form 4: Arteris COO Laurent Moll Executes Stock Sale

Sentiment:

Statement of Changes in Beneficial Ownership


Arteris, Inc. Chief Operating Officer Laurent Moll sold 13,448 shares of common stock via a pre-arranged 10b5-1 trading plan.

Summary

  • Chief Operating Officer Laurent Moll sold 13,448 shares of Arteris, Inc. common stock.
  • The transaction occurred on April 14, 2026.
  • The shares were sold at a weighted average price of $20.0313 per share.
  • The sale was executed under a Rule 10b5-1 trading plan adopted on March 12, 2026.
  • Following the transaction, the reporting person retains beneficial ownership of 265,530 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed under a pre-planned 10b5-1 arrangement, which is standard practice for executive compensation and liquidity management.

Positives

  • The sale was conducted through a pre-established 10b5-1 trading plan, which is a standard mechanism for executives to sell shares while avoiding concerns regarding insider trading.

Negatives

  • The transaction represents a reduction in the direct equity stake held by a key member of the executive leadership team.

Risks

  • Executive stock sales can sometimes be perceived negatively by the market as a signal of management's view on the company's current valuation.

Future Outlook

No forward-looking guidance or operational outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales via 10b5-1 plans are routine corporate governance events and generally do not reflect a change in company fundamentals or strategic direction.

Comparison to Industry Standards

  • The use of a 10b5-1 plan is the industry standard for executives to manage personal liquidity while maintaining compliance with SEC regulations.

Stakeholder Impact

  • Minimal impact expected as the sale was pre-planned and represents a small portion of the executive's total holdings.

Next Steps

  • No future actions or milestones were disclosed in this filing.

Key Dates

DateDescription
2026-03-12Date the 10b5-1 trading plan was adopted by the reporting person.
2026-04-14Date of the stock sale transaction.
2026-04-16Date the Form 4 filing was signed and submitted.

Keywords

Arteris, AIP, Insider Trading, Form 4, Chief Operating Officer, Stock Sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.